You are here

  • Home
  • Archive
  • Volume 12, Issue 6
  • Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC)

 

Online download statistics by month:

Online download statistics by month: June 2024 to September 2025

AbstractFullPdf
Jun 2024375379128
Jul 2024266267127
Aug 202410010363
Sep 2024677029
Oct 2024828239
Nov 2024656721
Dec 2024727421
Jan 2025606128
Feb 202514114117
Mar 2025484825
Apr 2025646433
May 2025484836
Jun 2025181911
Jul 2025110
Sep 2025110
Total14081425578